None listed
Conditions
Interventions
Intervention1: Bontress PRO+ Scalp Serum (51250129): The test product will be applied once daily to a clean and dry scalp and gently massaged for 5 minutes. The intervention will be continued for 84
Sponsors
Glenmark Pharmaceuticals Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: 1) Indian or Asian male & female subjects. 2)Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup) 3)Between 30 and 50 years of age. 4)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar .) 5)Having androgenetic alopecia of class I-2 to I-4 according to Ludwig and Savin Scale for females and class II to III (including III, IIIA and III vertex) according to Norwood Hamilton Scale for males.
Exclusion criteria
Exclusion criteria: 1)For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2)Having refused to give his/her assent by not signing the consent form Taking part in another study liable to interfere with this study 3)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area 4)Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 5)Having a progressive asthma (either under treatment or last fit in the last 2 years) 6)Being epileptic 7)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 8)Having cutaneous hypersensitivity 9)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products 10)Following a chronic or intermittent medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 11)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months 12)Having changed his/ her cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit 13)Having applied a cosmetic product on the studied areas the first day of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety on skin and hair growth i.e. improvement in AT ratio and reduction in hair fallTimepoint: Baseline, Day 28, Day 56 and Day 84 | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: NA | — |
Countries
India
Contacts
Public ContactDr Mohit Lalvani
MASCOT-SPINCONTROL India Pvt. Ltd.
Outcome results
None listed